NIDA Small Grant: This small grant application meets the funding priority: 1. Newer, less experienced investigator (PI). The applicant is in the end of the fourth year of a K08 entitled Drug Abuse, Pubertal Hormones, and AD/HD in Adolescence. This study will extend her work in the area of psychopharmacologic research in drug abuse in youth with Attention Deficit/Hyperactivity Disorder (AD/HD). This Phase 1 clinical trial will examine the safety and efficacy of modafinil and nicotine, alone and in combination, on abstinence-induced nicotine withdrawal in nicotine-dependent adolescents. Physiological, behavioral and subjective measures of impulsivity/inattention and depressive symptoms and other measures of nicotine withdrawal will be assessed in nicotine-dependent adolescents (16-18 years) who smoke 10 or more cigarettes per day and who started smoking before age 15. This study is based on the observations that impulsivity/inattention and depressive symptoms are associated with nicotine use, onset, dependence, withdrawal, cessation, and direct effects. Modafinil is a promising pharmacologic agent for the modification of symptoms of impulsivity/inattention and depression and is purported to have low abuse potential. It is hypothesized that modafinil will selectively diminish withdrawal-induced increases in impulsivity and depressive symptoms and offset reductions in attention, and the magnitude of these effects will be greater than those seen with nicotine replacement. In addition, it is hypothesized that the combination of modafinil and nicotine replacement will have a greater effect on nicotine withdrawal symptoms, particularly the withdrawal symptoms related to impulsivity/inattention and depression than either drug alone. This study will provide pilot data for an R01 submission that will investigate whether modafinil might be useful in the prevention of nicotine use and in a comprehensive behavioral and pharmacologic treatment intervention for early onset adolescent nicotine users.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Research Grants (R03)
Project #
1R03DA015413-01A1
Application #
6613107
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Montoya, Ivan
Project Start
2003-06-15
Project End
2005-05-31
Budget Start
2003-06-15
Budget End
2004-05-31
Support Year
1
Fiscal Year
2003
Total Cost
$73,459
Indirect Cost
Name
University of Kentucky
Department
Psychiatry
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Martin, Catherine Anne; Lile, Joshua; Guenthner, Greg et al. (2014) Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers. J Clin Psychopharmacol 34:278-81
Dosh, Tyanne; Helmbrecht, Tysa; Anestis, Joye et al. (2010) A comparison of the associations of caffeine and cigarette use with depressive and ADHD symptoms in a sample of young adult smokers. J Addict Med 4:52-4
Martin, Catherine A; Guenthner, Greg; Bingcang, Christopher et al. (2007) Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:63-73